Gastroenterology · for healthcare professionals
Two proton pump inhibitors from UROK Pharma for acid-related disorders: ESOROK® 40 mg and the new LansoDex 60 mg.
Established trust
Esomeprazole 40 mg capsules
Pack of 30 capsules
Esomeprazole is the S-isomer of omeprazole. It lowers gastric acid by inhibiting the H+/K+-ATPase, the proton pump of the parietal cell.
Healing of erosive esophagitis
20–40 mg once daily4 to 8 weeks
H. pylori eradicationwith amoxicillin 1000 mg and clarithromycin 500 mg, both twice daily
40 mg once daily10 days
Risk reduction of NSAID-associated gastric ulcer
20–40 mg once dailyup to 6 months
Zollinger-Ellison syndrome and other hypersecretory conditions
40 mg twice dailyadjusted to the patient
Take at least one hour before eating.
Do not chew or crush the capsule.
Open the capsule, mix the granules with a spoon of applesauce and swallow at once. Do not chew the granules.
A new chapter · new launch
Dexlansoprazole 60 mg modified-release capsules
Pack of 3 × 10 capsules
Dexlansoprazole is the R-enantiomer of lansoprazole. The capsule holds two types of enteric-coated granules that dissolve at different pH levels, so the dose is released in two phases.
Healing of all grades of erosive esophagitis
60 mg once dailyup to 8 weeks
Can be taken at any time relative to meals.
Do not chew the capsule or the granules.
Open the capsule, sprinkle the intact granules on a tablespoon of applesauce and swallow at once.
| ESOROK® | LansoDex | |
|---|---|---|
| Active ingredient | Esomeprazole | Dexlansoprazole |
| Molecule | S-isomer of omeprazole | R-enantiomer of lansoprazole |
| Strength | 40 mg | 60 mg |
| Capsule | Capsule | Modified-release capsule |
| Food | At least 1 hour before a meal | With or without food |
| Pack | 30 capsules | 3 × 10 capsules |
Contraindications: known hypersensitivity to the active substance or any excipient; use with rilpivirine-containing products.
Common adverse reactions: diarrhea, abdominal pain and nausea.
Use the lowest dose and the shortest treatment duration suited to the condition. For full prescribing information, see the approved product leaflet.